Guarantors - Cash Flows (Details) - USD ($) $ in Millions | 3 Months Ended |
Mar. 31, 2016 | Mar. 31, 2015 |
Condensed Consolidating Statements of Cash Flows | | |
Net income (loss) | $ 5.6 | $ (7.2) |
Equity income (loss) related to investment in subsidiaries | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 39.3 | 31.1 |
Non-cash interest expense | 0.9 | 0.7 |
Stock-based compensation expense | 3 | 3 |
Provision for bad debt write off | 0.1 | |
Asset impairments and loss on disposal | 0 | 8.6 |
Change in operating assets and liabilities: | | |
Rent receivables and other assets | 6.2 | 1.8 |
Accounts payable and accrued expenses | 0 | (2.9) |
Deferred revenues | (2.3) | (0.2) |
Due to affiliates | 0 | (1.6) |
Net cash provided by operating activities | 52.8 | 33.3 |
Cash flows from investing activities: | | |
Capital expenditures – purchase of fixed assets | (131.1) | (17.3) |
Capital expenditures – other development | (78.5) | (31.9) |
Investment in subsidiaries | 0 | |
Changes in restricted cash | 0.8 | |
Intercompany borrowings | 0 | 0 |
Return of investment | 0 | 0 |
Net cash used in investing activities | (208.8) | (49.2) |
Cash flows from financing activities: | | |
Issuance of common stock | 256 | 0 |
Dividends paid | (22.8) | (13.5) |
Intercompany borrowings | 0 | 0 |
Borrowings from credit facility | 320 | 20 |
Payments on credit facility | (305) | |
Payments on capital leases and leasing financing arrangements | (3.1) | (1.1) |
Tax payment upon exercise of equity awards | (13.6) | |
Contributions/distributions from parent | 0 | |
Debt issuance costs | (2.1) | 0 |
Net cash provided by financing activities | 229.4 | 5.4 |
Net increase (decrease) in cash and cash equivalents | 73.4 | (10.5) |
Cash and cash equivalents at beginning of period | 14.3 | 36.5 |
Cash and cash equivalents at end of period | 87.7 | 26 |
General Partner | | |
Condensed Consolidating Statements of Cash Flows | | |
Net income (loss) | 0.1 | (0.1) |
Equity income (loss) related to investment in subsidiaries | (0.1) | 0.1 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 0 | 0 |
Non-cash interest expense | 0 | 0 |
Stock-based compensation expense | 0 | 0 |
Provision for bad debt write off | 0 | |
Asset impairments and loss on disposal | | 0 |
Change in operating assets and liabilities: | | |
Rent receivables and other assets | 0 | 0 |
Accounts payable and accrued expenses | 0 | 0 |
Deferred revenues | 0 | 0 |
Due to affiliates | | 0 |
Net cash provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Capital expenditures – purchase of fixed assets | 0 | 0 |
Capital expenditures – other development | 0 | 0 |
Investment in subsidiaries | (2.6) | |
Changes in restricted cash | 0 | |
Intercompany borrowings | 0 | 0 |
Return of investment | 0 | 0 |
Net cash used in investing activities | (2.6) | 0 |
Cash flows from financing activities: | | |
Issuance of common stock | 0 | |
Dividends paid | 0 | 0 |
Intercompany borrowings | 0 | 0 |
Borrowings from credit facility | 0 | 0 |
Payments on credit facility | 0 | |
Payments on capital leases and leasing financing arrangements | 0 | 0 |
Tax payment upon exercise of equity awards | 0 | |
Contributions/distributions from parent | 2.6 | |
Debt issuance costs | 0 | |
Net cash provided by financing activities | 2.6 | 0 |
Net increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 |
Eliminations/Consolidations | | |
Condensed Consolidating Statements of Cash Flows | | |
Net income (loss) | (21.1) | 6.2 |
Equity income (loss) related to investment in subsidiaries | 21.5 | (5.5) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 0 | 0 |
Non-cash interest expense | 0 | 0 |
Stock-based compensation expense | 0 | 0 |
Provision for bad debt write off | 0 | |
Asset impairments and loss on disposal | | 0 |
Change in operating assets and liabilities: | | |
Rent receivables and other assets | 0 | 0 |
Accounts payable and accrued expenses | 0 | 0 |
Deferred revenues | 0 | 0 |
Due to affiliates | | 0 |
Net cash provided by operating activities | 0.4 | 0.7 |
Cash flows from investing activities: | | |
Capital expenditures – purchase of fixed assets | 0 | 0 |
Capital expenditures – other development | 0 | 0 |
Investment in subsidiaries | 514 | |
Changes in restricted cash | 0 | |
Intercompany borrowings | (40.6) | 20 |
Return of investment | (20.8) | (22.1) |
Net cash used in investing activities | 452.6 | (2.1) |
Cash flows from financing activities: | | |
Issuance of common stock | 0 | |
Dividends paid | 20.8 | 21.4 |
Intercompany borrowings | 40.2 | (20) |
Borrowings from credit facility | 0 | 0 |
Payments on credit facility | 0 | |
Payments on capital leases and leasing financing arrangements | 0 | 0 |
Tax payment upon exercise of equity awards | 0 | |
Contributions/distributions from parent | (514) | |
Debt issuance costs | 0 | |
Net cash provided by financing activities | (453) | 1.4 |
Net increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 |
Total Shareholders' Equity/ Parent’s Net Investment | | |
Condensed Consolidating Statements of Cash Flows | | |
Net income (loss) | 5.2 | (5) |
Equity income (loss) related to investment in subsidiaries | (5.2) | 5 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 0 | 0 |
Non-cash interest expense | 0 | 0 |
Stock-based compensation expense | 0 | 0 |
Provision for bad debt write off | 0 | |
Asset impairments and loss on disposal | | 0 |
Change in operating assets and liabilities: | | |
Rent receivables and other assets | 0 | 0 |
Accounts payable and accrued expenses | 0 | 0 |
Deferred revenues | 0 | 0 |
Due to affiliates | | 0 |
Net cash provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Capital expenditures – purchase of fixed assets | 0 | 0 |
Capital expenditures – other development | 0 | 0 |
Investment in subsidiaries | (255.7) | |
Changes in restricted cash | 0 | |
Intercompany borrowings | 13.5 | 0 |
Return of investment | 20.8 | 7.9 |
Net cash used in investing activities | (221.4) | 7.9 |
Cash flows from financing activities: | | |
Issuance of common stock | 256 | |
Dividends paid | (20.8) | (7.9) |
Intercompany borrowings | 0 | 0 |
Borrowings from credit facility | 0 | 0 |
Payments on credit facility | 0 | |
Payments on capital leases and leasing financing arrangements | 0 | 0 |
Tax payment upon exercise of equity awards | (13.6) | |
Contributions/distributions from parent | 0 | |
Debt issuance costs | 0 | |
Net cash provided by financing activities | 221.6 | (7.9) |
Net increase (decrease) in cash and cash equivalents | 0.2 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | 0.2 | 0 |
LP Co-issuer | | |
Condensed Consolidating Statements of Cash Flows | | |
Net income (loss) | 5.2 | (7.9) |
Equity income (loss) related to investment in subsidiaries | (16.9) | (0.4) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 0 | 0 |
Non-cash interest expense | 0.9 | 0.7 |
Stock-based compensation expense | 0 | 0 |
Provision for bad debt write off | 0 | |
Asset impairments and loss on disposal | | 0 |
Change in operating assets and liabilities: | | |
Rent receivables and other assets | 0 | 0 |
Accounts payable and accrued expenses | 7.1 | 10.4 |
Deferred revenues | 0 | 0 |
Due to affiliates | | 0 |
Net cash provided by operating activities | (3.7) | 2.8 |
Cash flows from investing activities: | | |
Capital expenditures – purchase of fixed assets | 0 | 0 |
Capital expenditures – other development | 0 | 0 |
Investment in subsidiaries | (255.7) | |
Changes in restricted cash | 0 | |
Intercompany borrowings | 27.1 | (20) |
Return of investment | 0 | 10.7 |
Net cash used in investing activities | (228.6) | (9.3) |
Cash flows from financing activities: | | |
Issuance of common stock | 0 | |
Dividends paid | (22.8) | (13.5) |
Intercompany borrowings | (13.5) | 0 |
Borrowings from credit facility | 320 | 20 |
Payments on credit facility | (305) | |
Payments on capital leases and leasing financing arrangements | 0 | 0 |
Tax payment upon exercise of equity awards | 0 | |
Contributions/distributions from parent | 255.7 | |
Debt issuance costs | (2.1) | |
Net cash provided by financing activities | 232.3 | 6.5 |
Net increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 |
Finance Co-issuer | | |
Condensed Consolidating Statements of Cash Flows | | |
Net income (loss) | 0 | 0 |
Equity income (loss) related to investment in subsidiaries | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 0 | 0 |
Non-cash interest expense | 0 | 0 |
Stock-based compensation expense | 0 | 0 |
Provision for bad debt write off | 0 | |
Asset impairments and loss on disposal | | 0 |
Change in operating assets and liabilities: | | |
Rent receivables and other assets | 0 | 0 |
Accounts payable and accrued expenses | 0 | 0 |
Deferred revenues | 0 | 0 |
Due to affiliates | | 0 |
Net cash provided by operating activities | 0 | 0 |
Cash flows from investing activities: | | |
Capital expenditures – purchase of fixed assets | 0 | 0 |
Capital expenditures – other development | 0 | 0 |
Investment in subsidiaries | 0 | |
Changes in restricted cash | 0 | |
Intercompany borrowings | 0 | 0 |
Return of investment | 0 | 0 |
Net cash used in investing activities | 0 | 0 |
Cash flows from financing activities: | | |
Issuance of common stock | 0 | |
Dividends paid | 0 | 0 |
Intercompany borrowings | 0 | 0 |
Borrowings from credit facility | 0 | 0 |
Payments on credit facility | 0 | |
Payments on capital leases and leasing financing arrangements | 0 | 0 |
Tax payment upon exercise of equity awards | 0 | |
Contributions/distributions from parent | 0 | |
Debt issuance costs | 0 | |
Net cash provided by financing activities | 0 | 0 |
Net increase (decrease) in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | 0 | 0 |
Guarantor Subsidiaries | | |
Condensed Consolidating Statements of Cash Flows | | |
Net income (loss) | 16.9 | 0.4 |
Equity income (loss) related to investment in subsidiaries | 0.7 | 0.8 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 38.6 | 30.5 |
Non-cash interest expense | 0 | 0 |
Stock-based compensation expense | 3 | 3 |
Provision for bad debt write off | 0.1 | |
Asset impairments and loss on disposal | | 8.6 |
Change in operating assets and liabilities: | | |
Rent receivables and other assets | 6 | 0.1 |
Accounts payable and accrued expenses | (7.1) | (13.3) |
Deferred revenues | (2.2) | (0.2) |
Due to affiliates | | (1.6) |
Net cash provided by operating activities | 56 | 28.3 |
Cash flows from investing activities: | | |
Capital expenditures – purchase of fixed assets | (131.1) | (17.3) |
Capital expenditures – other development | (78.5) | (31.8) |
Investment in subsidiaries | 0 | |
Changes in restricted cash | 0.8 | |
Intercompany borrowings | 0 | 0 |
Return of investment | 0 | 3.7 |
Net cash used in investing activities | (208.8) | (45.4) |
Cash flows from financing activities: | | |
Issuance of common stock | 0 | |
Dividends paid | 0 | (13.5) |
Intercompany borrowings | (26.7) | 20 |
Borrowings from credit facility | 0 | 0 |
Payments on credit facility | 0 | |
Payments on capital leases and leasing financing arrangements | (2) | (0.9) |
Tax payment upon exercise of equity awards | 0 | |
Contributions/distributions from parent | 255.7 | |
Debt issuance costs | 0 | |
Net cash provided by financing activities | 227 | 5.6 |
Net increase (decrease) in cash and cash equivalents | 74.2 | (11.5) |
Cash and cash equivalents at beginning of period | 10.4 | 33.5 |
Cash and cash equivalents at end of period | 84.6 | 22 |
Non- Guarantor Subsidiaries | | |
Condensed Consolidating Statements of Cash Flows | | |
Net income (loss) | (0.7) | (0.8) |
Equity income (loss) related to investment in subsidiaries | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Depreciation and amortization | 0.7 | 0.6 |
Non-cash interest expense | 0 | 0 |
Stock-based compensation expense | 0 | 0 |
Provision for bad debt write off | 0 | |
Asset impairments and loss on disposal | | 0 |
Change in operating assets and liabilities: | | |
Rent receivables and other assets | 0.2 | 1.7 |
Accounts payable and accrued expenses | 0 | 0 |
Deferred revenues | (0.1) | 0 |
Due to affiliates | | 0 |
Net cash provided by operating activities | 0.1 | 1.5 |
Cash flows from investing activities: | | |
Capital expenditures – purchase of fixed assets | 0 | 0 |
Capital expenditures – other development | 0 | (0.1) |
Investment in subsidiaries | 0 | |
Changes in restricted cash | 0 | |
Intercompany borrowings | 0 | 0 |
Return of investment | 0 | (0.2) |
Net cash used in investing activities | 0 | (0.3) |
Cash flows from financing activities: | | |
Issuance of common stock | 0 | |
Dividends paid | 0 | 0 |
Intercompany borrowings | 0 | 0 |
Borrowings from credit facility | 0 | 0 |
Payments on credit facility | 0 | |
Payments on capital leases and leasing financing arrangements | (1.1) | (0.2) |
Tax payment upon exercise of equity awards | 0 | |
Contributions/distributions from parent | 0 | |
Debt issuance costs | 0 | |
Net cash provided by financing activities | (1.1) | (0.2) |
Net increase (decrease) in cash and cash equivalents | (1) | 1 |
Cash and cash equivalents at beginning of period | 3.9 | 3 |
Cash and cash equivalents at end of period | $ 2.9 | $ 4 |